CNS Pharmaceuticals, Inc. (CNSP) Net income 2018–2025
CNS Pharmaceuticals, Inc. (CNSP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$15.9MFY2025 · since FY2018: -$7.4M → -$15.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.9M | -6.7% |
| FY2024 | -$14.9M | +21.2% |
| FY2023 | -$18.9M | -23.4% |
| FY2022 | -$15.3M | -5.4% |
| FY2021 | -$14.5M | -53.3% |
| FY2020 | -$9.5M | -143.9% |
| FY2019 | -$3.9M | +47.5% |
| FY2018 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice